1. Home
  2. MDGL vs GL Comparison

MDGL vs GL Comparison

Compare MDGL & GL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDGL
  • GL
  • Stock Information
  • Founded
  • MDGL 2011
  • GL 1900
  • Country
  • MDGL United States
  • GL United States
  • Employees
  • MDGL N/A
  • GL N/A
  • Industry
  • MDGL Biotechnology: Pharmaceutical Preparations
  • GL Life Insurance
  • Sector
  • MDGL Health Care
  • GL Finance
  • Exchange
  • MDGL Nasdaq
  • GL Nasdaq
  • Market Cap
  • MDGL 9.6B
  • GL 11.0B
  • IPO Year
  • MDGL N/A
  • GL N/A
  • Fundamental
  • Price
  • MDGL $530.11
  • GL $134.37
  • Analyst Decision
  • MDGL Strong Buy
  • GL Buy
  • Analyst Count
  • MDGL 13
  • GL 10
  • Target Price
  • MDGL $523.92
  • GL $150.90
  • AVG Volume (30 Days)
  • MDGL 409.9K
  • GL 600.6K
  • Earning Date
  • MDGL 11-04-2025
  • GL 10-22-2025
  • Dividend Yield
  • MDGL N/A
  • GL 0.82%
  • EPS Growth
  • MDGL N/A
  • GL 16.72
  • EPS
  • MDGL N/A
  • GL 13.77
  • Revenue
  • MDGL $740,640,000.00
  • GL $5,940,974,000.00
  • Revenue This Year
  • MDGL $395.75
  • GL $7.51
  • Revenue Next Year
  • MDGL $65.73
  • GL $5.15
  • P/E Ratio
  • MDGL N/A
  • GL $9.61
  • Revenue Growth
  • MDGL 864.21
  • GL 3.73
  • 52 Week Low
  • MDGL $265.00
  • GL $100.27
  • 52 Week High
  • MDGL $544.25
  • GL $147.83
  • Technical
  • Relative Strength Index (RSI)
  • MDGL 74.00
  • GL 49.21
  • Support Level
  • MDGL $399.00
  • GL $130.50
  • Resistance Level
  • MDGL $544.25
  • GL $134.62
  • Average True Range (ATR)
  • MDGL 27.05
  • GL 2.17
  • MACD
  • MDGL 11.07
  • GL 0.24
  • Stochastic Oscillator
  • MDGL 91.20
  • GL 84.44

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.

About GL Globe Life Inc.

Globe Life Inc is an insurance holding company. It provides a variety of life and supplemental health insurance products and annuities to a broad base of customers. The company's core operations are organized into three reportable segments: life insurance, supplemental health insurance and investments. Investment activities, conducted by the investment segment, focus on seeking investments with a yield and term appropriate to support the insurance product obligations. These investments generally consist of fixed maturities and, over the long term, the expected yields are considered when setting insurance premium rates and product profitability expectations.

Share on Social Networks: